Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - Journal of clinical …, 2012 - ascopubs.org
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …

[PDF][PDF] Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - J Clin Oncol, 2011 - Citeseer
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …

[PDF][PDF] Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - 2011 - researchgate.net
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …

[引用][C] Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non-Small-Cell Lung Cancer

GV SCAGLIOTTI, U PASTORINO… - Journal of clinical …, 2012 - pascal-francis.inist.fr
Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and
Gemcitabine in Stages IB to IIIA Non-Small-Cell Lung Cancer CNRS Inist Pascal-Francis CNRS …

Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - Journal of Clinical …, 2012 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This study aimed to determine whether
three preoperative cycles of gemcitabine plus cisplatin followed by radical surgery provides …

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer

GV Scagliotti, U Pastorino… - Journal of clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

GV Scagliotti, U Pastorino… - Journal of Clinical …, 2011 - europepmc.org
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - JOURNAL OF …, 2012 - air.unimi.it
This study aimed to determine whether three preoperative cycles of gemcitabine plus
cisplatin followed by radical surgery provides a reduction in the risk of progression …

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

GV Scagliotti, U Pastorino, J Vansteenkiste… - JOURNAL OF …, 2012 - iris.unito.it
This study aimed to determine whether three preoperative cycles of gemcitabine plus
cisplatin followed by radical surgery provides a reduction in the risk of progression …

[PDF][PDF] Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer

GV Scagliotti, U Pastorino, JF Vansteenkiste… - J Clin Oncol, 2011 - academia.edu
Purpose This study aimed to determine whether three preoperative cycles of gemcitabine
plus cisplatin followed by radical surgery provides a reduction in the risk of progression …